AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,607 | -20.6% | 671 | -9.2% | 0.00% | -100.0% |
| Q2 2023 | $20,928 | +18.8% | 739 | -3.7% | 0.00% | – |
| Q1 2023 | $17,618 | -36.0% | 767 | -21.8% | 0.00% | -100.0% |
| Q4 2022 | $27,546 | -1.6% | 981 | -2.2% | 0.00% | 0.0% |
| Q3 2022 | $28,000 | +133.3% | 1,003 | +92.5% | 0.00% | – |
| Q2 2022 | $12,000 | +300.0% | 521 | +337.8% | 0.00% | – |
| Q1 2022 | $3,000 | +200.0% | 119 | +164.4% | 0.00% | – |
| Q4 2021 | $1,000 | -66.7% | 45 | -38.4% | 0.00% | – |
| Q3 2021 | $3,000 | -70.0% | 73 | -59.0% | 0.00% | – |
| Q2 2021 | $10,000 | +66.7% | 178 | +61.8% | 0.00% | – |
| Q1 2021 | $6,000 | +100.0% | 110 | +50.7% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | +50.0% | 73 | +92.1% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 38 | +5.6% | 0.00% | – |
| Q1 2020 | $1,000 | -66.7% | 36 | -33.3% | 0.00% | – |
| Q4 2019 | $3,000 | +200.0% | 54 | +200.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 18 | -63.3% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 49 | +75.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |